Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1639 1675 1678 1682 1683 1684
This examiner grants 0% of resolved cases
Khai Quynh Tien Pham is an examiner in Art Unit 1637 within Tech Center 1600. The current data is based on 1 resolved case, which resulted in an allowance rate of 0.0 percent. This resolution also reflects an interview lift of 0.0 percent. For applications that reach allowance, the median time is 1214 days. These figures represent a limited sample size, but they establish the initial baseline for prosecution timelines and outcomes in this specific art unit.
Practitioners should monitor how these metrics evolve as more cases are resolved. The 0.0 percent allowance rate and 1214-day median pendency suggest a cautious approach to prosecution in the early stages of this examiner's tenure. Without more data, the lack of a recorded interview lift should be viewed as preliminary rather than a definitive indicator of the effectiveness of oral advocacy in Art Unit 1637. This baseline provides a starting point for evaluating the examiner's approach to patentability and procedural efficiency.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18397280 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | Non-Final OA | Life Technologies Corporation |
| 18345856 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | Non-Final OA | Life Technologies Corporation |
| 18377068 | Methods and Systems for Processing Polynucleotides | Non-Final OA | 10X GENOMICS, INC. |
| 18213088 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DETECTING EXOGENOUS NUCLEIC ACIDS | Non-Final OA | 10x Genomics, Inc. |
| 18290550 | PARTITIONING CELLS FOR HIGH THROUGHPUT SINGLE-CELL SEQUENCING | Non-Final OA | The Regents of the University of California |
| 18268538 | BIOCATALYTIC PLATFORM FOR CHEMICAL SYNTHESIS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18561262 | Multiple Feature Integration With Next-Generation Three-Dimensional in Situ Sequencing | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18054503 | PARALLEL SINGLE-CELL REPORTER ASSAYS AND COMPOSITIONS | Final Rejection | Washington University |
| 18512453 | METHODS AND SYSTEMS FOR DETECTING PEPTIDE AGGREGATES | Non-Final OA | Rensselaer Polytechnic Institute |
| 18652519 | DIGITAL COUNTING OF INDIVIDUAL MOLECULES BY STOCHASTIC ATTACHMENT OF DIVERSE LABELS | Non-Final OA | Becton, Dickinson and Company |
| 18634901 | ARTIFICIAL PROTEINS FOR DISPLAYING EPITOPES | Non-Final OA | Nautilus Subsidiary, Inc. |
| 18654545 | HIGH-THROUGHPUT SINGLE-CELL SEQUENCING WITH REDUCED AMPLIFICATION BIAS | Non-Final OA | University of Washington |
| 18649435 | MASSIVELY PARALLEL CONTIGUITY MAPPING | Non-Final OA | University of Washington through its Center for Commercialization |
| 18268470 | METHOD FOR SCREENING FOR CANDIDATE MOLECULE CAPABLE OF FORMING COMPLEX IN CONJUNCTION WITH PLURALITY OF TARGET MOLECULES | Final Rejection | Chugai Seiyaku Kabushiki Kaisha |
| 17926566 | NUCLEIC ACID SAMPLE ENRICHMENT AND SCREENING METHODS | Non-Final OA | Myriad Women's Health, Inc. |
| 18548864 | MOLECULAR BARCODES AND RELATED METHODS AND SYSTEMS | Non-Final OA | Oregon Health & Science University |
| 18571069 | APTAMER DYNAMIC RANGE COMPRESSION AND DETECTION TECHNIQUES | Non-Final OA | ILLUMINA, INC. |
| 18473564 | Compositions and Methods for Assessing DNA Damage in a Library and Normalizing Amplicon Size Bias | Non-Final OA | Illumina, Inc. |
| 18703128 | TARGET ENRICHMENT AND QUANTIFICATION UTILIZING ISOTHERMALLY LINEAR-AMPLIFIED PROBES | Non-Final OA | The Children's Hospital of Philadelphia |
| 17980755 | SYSTEMS AND METHODS FOR PREPARING BIOLOGICAL SAMPLES FOR GENETIC SEQUENCING | Final Rejection | Universal Diagnostics, S.A. |
| 18168528 | COMBINATORIAL DNA ASSEMBLY FOR MULTISPECIFIC ANTIBODIES | Final Rejection | TWIST BIOSCIENCE CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy